셀메드 (CELLMED)

  • 제9권1호
  • /
  • Pages.1.1-1.13
  • /
  • 2019
  • /
  • 3022-6805(pISSN)
  • /
  • 3022-6791(eISSN)
셀메드 세포교정의약학회 (Cellmed Orthocellular Medicine and Pharmaceutical Association)
권호 표지
DOI QR코드

DOI QR Code

A bioassay system for pharmacological standardization of Withania somnifera derived herbal remedies

  • Dey, Amitabha (Neuropharmacology Research Laboratory, Department of Pharmaceutical Engineering and Technology, Indian Institute of Technology (Banaras Hindu University)) ;
  • Chatterjee, Shyam Sunder (Stettiner Strasse 1) ;
  • Kumar, Vikas (Neuropharmacology Research Laboratory, Department of Pharmaceutical Engineering and Technology, Indian Institute of Technology (Banaras Hindu University))
  • 투고 : 2018.12.04
  • 심사 : 2019.02.21
  • 발행 : 2019.02.28
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Background: Contents of bioactive substances extractable from different parts of terrestrial plants vary enormously. Aim: To ascertain that parts of Withania somnifera other than its roots can also be used for prevention and cure of unavoidable stress triggered central hypersensitivity to pain. Material and Methods: Groups of male or female mice treated either with Withania somnifera extracts or with metformin, aspirin, imipramine, diazepam and niacin for 11 consecutive days were subjected to "foot-shock stress-induced hyperthermia" and "hot plate" tests on the 1st, 5th, 7th, and 10th days of the experiments. On the 11th day, they were subjected to tail suspension test and on 12th day pentobarbital hypnosis test. Results: Except for diazepam and imipramine, protective effects of all other tested drugs as well as of the Withania somnifera extracts against stress-induced central hypersensitivity to pain were accompanied by their preventive effects against foot-shock stress-induced body weight losses. All observed stress response suppressing effects of all test agents increased with increasing numbers of treatment days. However, mean duration of pentobarbital-induced sleep was shorter in the extracts treated groups and longer in the diazepam treated ones only. Conclusions: Reported observations reveal that pharmacological activity profile of Withania somnifera extracts in male and female mice are almost identical, and are not like those of several drugs currently often prescribed for the treatment of diabetes-associated comorbidities. Withanolides are not the only extractable bioactive constituents of Withania somnifera. The described bioassay system is well suited for pharmacological standardization of diverse types of Withania somnifera extracts.

키워드

TJHOBI_2019_v9n1_1.1_f0001.png 이미지

Fig.1 HPLC fingerprints of A) WSR (total content of Withanolides =2.7%), B) WSA (Total content of Withanolides = 1.5%), and C) WSS(total contents of Withanolides = 3.0%).

TJHOBI_2019_v9n1_1.1_f0002.png 이미지

Fig.2 Summary of the experimental procedures and tests used.

TJHOBI_2019_v9n1_1.1_f0003.png 이미지

Fig.3 Effect of occasional foot shock stress (duration 50 seconds) on mean body weight of male (A and B) and female mice (C and D) treated eitherwith the extracts of roots (WSR), stems (WSS) or areal parts (WSA) of Withania somnifera, or with diazepam (DZP) imipramine (IMIP), metformin(MET), nicotinic acid (NA), or aspirin (ASA) during the course of the experiments.

TJHOBI_2019_v9n1_1.1_f0004.png 이미지

Fig.4 Effect of occasional foot shock stress (duration 50 seconds) on mean basal core temperatures of male (A and B) and female mice (C and D) treated either with the extracts of roots (WSR), stems (WSS) or areal parts (WSA) of Withania somnifera, or with diazepam (DZP) imipramine (IMIP), metformin (MET), nicotinic acid (NA), or aspirin (ASA) during the course of the experiments.

TJHOBI_2019_v9n1_1.1_f0005.png 이미지

Fig. 5 Effect of occasional foot shock stress (duration 50 seconds) on stress induced hyperthermia of male (A and B) and female mice (C and D) treated either with the extracts of roots (WSR), stems (WSS) or areal parts (WSA) of Withania somnifera, or with diazepam (DZP) imipramine (IMIP), metformin (MET), nicotinic acid (NA), or aspirin (ASA) during the course of the experiments.

TJHOBI_2019_v9n1_1.1_f0006.png 이미지

Fig. 6 Effect of occasional foot shock stress (duration 50 seconds) on hot plate reaction time of male (A and B) and female mice (C and D) treated either with the extracts of roots (WSR), stems (WSS) or areal parts (WSA) of Withania somnifera, or with diazepam (DZP) imipramine (IMIP), metformin (MET), nicotinic acid (NA), or aspirin (ASA) during the course of the experiments.

TJHOBI_2019_v9n1_1.1_f0007.png 이미지

Fig. 7 Effect of occasional foot shock stress (duration 50 seconds) on tail suspension test of male (A and B) and female mice (C and D) treated either with the extracts of roots (WSR), stems (WSS) or areal parts (WSA) of Withania somnifera, or with diazepam (DZP) imipramine (IMIP), metformin (MET), nicotinic acid (NA), or aspirin (ASA) during the course of the experiments.

TJHOBI_2019_v9n1_1.1_f0008.png 이미지

Fig.8 Effect of occasional foot shock stress (duration 50 seconds) on pentobarbital induced sleep test of male (A and B) and female mice (C and D) treated either with the extracts of roots (WSR), stems (WSS) or areal parts (WSA) of Withania somnifera, or with diazepam (DZP) imipramine (IMIP), metformin (MET), nicotinic acid (NA), or aspirin (ASA) during the course of the experiments.

참고문헌

  1. Alam N, Hossain M, Khalil MI, Moniruzzaman M, Sulaiman SA, Gan SH. High catechin concentrations detected in Withania somnifera (ashwagandha) by high performance liquid chromatography analysis. BMC Complement Altern Med 2011:11(1): 65. https://doi.org/10.1186/1472-6882-11-65
  2. Ameh SJ, Toge BK, Ebeshi BU, Ambi AA, Garba M, Alfa J, Gamaniel KS. Herbal Drug Development from Traditional Formulations: Refocusing Pharmaceutics and Posology for Accelerated Validation. Brit J Pharm Res. 2014:4(12):1451-76. https://doi.org/10.9734/BJPR/2014/10617
  3. Andrew R, Izzo AA. Principles of pharmacological research of nutraceuticals. Br J Pharmacol. 2017:174(11):1177-94. https://doi.org/10.1111/bph.13779
  4. Balasubramani SP, Venkatasubramanian P, Kukkupuni SK, Patwardhan B. Plant-based Rasayana drugs from Ayurveda. Chin J Integr Med/ 2011:17(2):88-94. https://doi.org/10.1007/s11655-011-0659-5
  5. Berk M, Dean O, Drexhage H, McNeil JJ, Moylan S, O'Neil A, Davey CG, Sanna L, Maes M. Aspirin: a review of its neurobiological properties and therapeutic potential for mental illness. BMC Med. 2013:11:74. https://doi.org/10.1186/1741-7015-11-74
  6. Bharti SK, Bhatia A, Tewari SK, Sidhu OP, Roy R. Application of HR-MAS NMR spectroscopy for studying chemotype variations of Withania somnifera (L.) Dunal. Magn Reson Chem. 2011:49(10): 659-667. https://doi.org/10.1002/mrc.2817
  7. Bhatia A, Bharti SK, Tewari SK, Sidhu OP, Roy R. Metabolic profiling for studying chemotype variations in Withania somnifera (L.) Dunal fruits using GC-MS and NMR spectroscopy. Phytochemistry. 2013:93:105-15. https://doi.org/10.1016/j.phytochem.2013.03.013
  8. Can A, Dao DT, Terrillion CE, Piantadosi SC, Bhat S, Gould TD. The tail suspension test. J Vis Exp. 2012:59:3769.
  9. Chatterjee S, Srivastava S, Khalid A, Singh N, Sangwan RS, Sidhu OP, Roy R, Khetrapal CL, Tuli, R. Comprehensive metabolic fingerprinting of Withania somnifera leaf and root extracts. Phytochemistry. 2010:71(10):1085-94. https://doi.org/10.1016/j.phytochem.2010.04.001
  10. Chatterjee SS, Kumar V. Quantitative Systems Pharmacology: Lessons from Fumaric acid and Herbal Remedies. Drug Designing. 2017:6(152):1-9.
  11. Dar NJ, Hamid A, Ahmad M. Pharmacologic overview of Withania somnifera the Indian Ginseng. Cell Mol Life Sci. 2015:72: 4445-60. https://doi.org/10.1007/s00018-015-2012-1
  12. Dey A, Chatterjee SS, Kumar V. Analgesic activity of a Withania somnifera extract in stressed mice. Orient Pharm Exp Med. 2016:16(4):295-302. https://doi.org/10.1007/s13596-016-0245-7
  13. Dey A, Chatterjee SS, Kumar V. Low dose effects of a Withania somnifera extract on altered marble burying behavior in stressed mice. J Intercult Ethnopharmacol. 2016:5(3): 274-277. https://doi.org/10.5455/jice.20160414104917
  14. Hankin BL, Abramson LY. Development of gender differences in depression: An elaborated cognitive vulnerability transactional stress theory. Psychol Bull. 2001:127(6): 773-796. https://doi.org/10.1037/0033-2909.127.6.773
  15. Kaushik MK, Kaul SC, Wadhwa R, Yanagisawa M, Urade Y. Triethylene glycol, an active component of Ashwagandha (Withania somnifera) leaves, is responsible for sleep induction. PLoS One. 2017:12(2):e0172508. https://doi.org/10.1371/journal.pone.0172508
  16. Khan SA, Chatterjee SS, Kumar V. Low dose aspirin like analgesic and anti-inflammatory activities of monohydroxybenzoic acids in stressed rodents. Life Sci. 2016:148:53-62. https://doi.org/10.1016/j.lfs.2016.02.032
  17. Dempsey DA, Klessig DF. How does the multifaceted plant hormone salicylic acid combat disease in plants and are similar mechanisms utilized in humans? BMC Biol. 2017:15(1): 23. https://doi.org/10.1186/s12915-017-0364-8
  18. Kumar A, Kaul MK, Bhan MK, Khanna PK, Suri KA. Morphological and chemical variation in 25 collections of the Indian medicinal plant, Withania somnifera (L.) Dunal (Solanaceae). Genet Resour Crop Evol. 2007:54(3) 655-660. https://doi.org/10.1007/s10722-006-9129-x
  19. Kumar V, Dey A, Chatterjee SS Phytopharmacology of Ashwagandha as an Anti-Diabetic Herb. In: Science of Ashwagandha: Preventive and Therapeutic Potentials. Kaul SC, Wadhwa R. ed. (Basel, Switzerland: Springer International Publishing), pp.37-68, 2017.
  20. Kumar V, Dey A, Hadimani MB, Marcovic T, Emerald M Chemistry and pharmacology of Withania somnifera: An update. TANG [Humanitas Medicine]. 2015:5: e1.
  21. Kumar V, Thakur AK, Verma S, Yadav V, Chatterjee SS. Potential of some traditionally used edible plants for prevention and cure of diabesity associated comorbidities. TANG [Humanitas Medicine]. 2015:5(2):8.1-8.22. https://doi.org/10.5667/tang.2014.0026
  22. Mathur R, Velpandian T Medicinal plant-based health products: Where is the medicinal constituent? Indian J Pharmacol. 2009:41(4):205-206. https://doi.org/10.4103/0253-7613.56063
  23. Murthy HN, Dijkstra C, Anthony P, White DA, Davey MR, Power JB, Hahn EJ, Paek KY. Establishment of Withania somnifera hairy root cultures for the production of withanolide A. J Integr Plant Biol 2008:50(8):975-81. https://doi.org/10.1111/j.1744-7909.2008.00680.x
  24. Ojima K, Matsumoto K, Tohda M, Watanabe H. Hyperactivity of central noradrenergic and CRF system is involved in social isolation-induced decrease in pentobarbital sleep. Brain Res. 1995:684(1):87-94. https://doi.org/10.1016/0006-8993(95)00388-7
  25. Olff M, Langeland W, Draijer N, Gersons BP. Gender differences in posttraumatic stress disorder. Psychol Bull. 2007:133(2):183-204. https://doi.org/10.1037/0033-2909.133.2.183
  26. Orru A, Casu MA, Tambaro S, Marchese G, Casu G, Ruiu S. Withania somnifera (L.) Dunal root extract alleviates formalin-induced nociception in mice: involvement of the opioidergic system. Behav Pharmacol. 2016:27(1):57-68. https://doi.org/10.1097/FBP.0000000000000195
  27. Pal A, Kumar M, Saharan V, Bhushan B. Antioxidant and free radical scavenging activity of Ashwagandha (Withania somnifera L.) leaves. Journal of Global Biosciences 2015:4(1): 1127-37.
  28. Pratibha C, Madhumati B, Akarsh P. Therapeutic Properties and Significance of Different parts of Ashwagandha-A Medicinal Plant. International Journal of Pure & Applied Bioscience. 2013:1(6):94-101.
  29. Rahola JG. Somatic drugs for psychiatric diseases: aspirin or simvastatin for depression?. Curr Neuropharmacol. 2012:10(2):139-58. https://doi.org/10.2174/157015912800604533
  30. Rai M, Jogee PS, Agarkar G, dos Santos CA. Anticancer activities of Withania somnifera: Current research, formulations, and future perspectives. Pharm Biol. 2016:54(2):189-97. https://doi.org/10.3109/13880209.2015.1027778
  31. Rauniyar BK, Shakya A, Thakur AK, Chatterjee SS, Kumar V. Anti-Stress Activity of Phloroglucinol: A Transient Metabolite of Some Plant Polyphenolics. Pharmacologia. 2015:6:21-30. https://doi.org/10.5567/pharmacologia.2015.21.30
  32. Rayees S, Malik F. Withania somnifera: From Traditional Use to Evidence Based Medicinal Prominence. In: Science of Ashwagandha: Preventive and Therapeutic Potentials. Kaul SC, Wadhwa R. ed. (Basel, Switzerland: Springer International Publishing), pp.81-103, 2017.
  33. Sangwan RS, Chaurasiya ND, Misra LN, Lal P, Uniyal GC, Sharma R, Sangwan NS, Suri KA, Qazi GN and Tuli R. Phytochemical variability in commercial herbal products and preparations of Withania somnifera (Ashwagandha). Curr Sci. 2004:86(3):461-465.
  34. Shrivastava N, Dey A, Chatterjee SS, Kumar V. Adaptogenic Potential of Triethylene Glycol and Quercetin in Stressed Mice. Pharm Pharmacol Int J. 2015:2(6):197-206
  35. Singh B, Chandan BK, Gupta DK. Adaptogenic activity of a novel withanolide-free aqueous fraction from the roots of Withania somnifera Dun. (Part II). Phytother Res. 2003:17: 531-536. https://doi.org/10.1002/ptr.1189
  36. Singh B, Saxena AK, Chandan BK, Gupta DK, Bhutani KK, Anand KK. Adaptogenic activity of a novel, withanolide-free aqueous fraction from the roots of Withania somnifera Dun. Phytother Res. 2001:15:311-318. https://doi.org/10.1002/ptr.858
  37. Singh N, Bhalla M, de Jager P, Gilca M. Ashwagandha, An overview on ashwagandha: a Rasayana (rejuvenator) of Ayurveda. Afr J Tradit Complement Altern Med. 2011:8(5 Suppl):208-13.
  38. Thakur AK, Dey A, Chatterjee SS, Kumar V. Reverse Ayurvedic pharmacology of Ashwagandha as an adaptogenic anti-diabetic plant: a pilot study. Curr Trad Med. 2015:1:51-61. https://doi.org/10.2174/2215083801999150527115205
  39. Turner RA. Analgesics. In Screening methods in pharmacology. (New York, USA: Academic Press), pp.100-102, 1965
  40. Virk JK, Bansal P, Gupta V, Kumar S, Singh R. Lack of pharmacological basis of substitution of an endangered plant group Ashtawarga-A significant ingredient of polyherbal formulations. American Journal of Phytomedicine and Clinical Therapeutics. 2015:2:690-712.
  41. Virk JK, Gupta V, Kumar S, Singh R, Bansal P. Ashtawarga plants-Suffering a triple standardization syndrome. J Tradit Complement Med. 2017:7(4):392-99. https://doi.org/10.1016/j.jtcme.2016.12.011
  42. Wadhwa R, Singh R, Gao R, Shah N, Widodo N, Nakamoto T, Ishida Y, Terao K, Kaul SC. Water extract of Ashwagandha leaves has anticancer activity: identification of an active component and its mechanism of action. PLoS One. 2013:8(10):e77189. https://doi.org/10.1371/journal.pone.0077189
  43. Winston D, Maimes S. Adaptogens: Herbs for Strength, Stamina, and Stress Relief. (Vermont, USA : Inner Traditions-Bear & Co.), 2007.
  44. Yunus MB. Fibromyalgia and overlapping disorders: the unifying concept of central sensitivity syndromes. Semin Arthritis Rheum. 2007;36(6): 339-356. doi:10.1016/j.semarthrit.2006.12.009.
  45. Yunus MB. Thematic issue: an update on central sensitivity syndromes and the issues of nosology and psychobiology. Curr Rheumatol Rev. 2015;11(2): 70-85. https://doi.org/10.2174/157339711102150702112236
  46. Zhou J, Chan L, Zhou S. Trigonelline: a plant alkaloid with therapeutic potential for diabetes and central nervous system disease. Curr Med Chem 2012;19(21): 3523-31. https://doi.org/10.2174/092986712801323171